Phio Pharmaceuticals Announces Invitation for Oral Presentation at 41st Annual SITC Meeting
INTASYL siRNA – Redefining the Treatment Paradigm for Cutaneous Squamous Cell Carcinoma Phio Pharmaceuticals Corp. (NASDAQ:PHIO) KING OF PRUSSIA, PA, UNITED STATES, November 6, 2026 /EINPresswire.com/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a …